Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
CLOSE ×
Search
Leaving AARP.org Website

You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

What to Know About Arcturus, the Latest COVID Variant

Experts say the strain, formally known as XBB.1.16, could cause a summer surge


spinner image Conceptual paper illustration of human hands and coronavirus in a lab. Flat lay top-down composition on green background.
Eugene Mymrin

Health officials and virus experts are keeping a close eye on a new subvariant of omicron that’s been reported in nearly 30 countries and is growing its presence in the U.S.

Nicknamed Arcturus, and technically referred to as XBB.1.16, the strain is behind an estimated 12 percent of new COVID-19 cases in the U.S., up from 7.4 percent the previous week, data from the Centers for Disease Control and Prevention (CDC) shows. Judging by patterns seen in other countries — especially India, where XBB.1.16 is more widespread — Matthew Binnicker, director of the Clinical Virology Laboratory at Mayo Clinic, predicts the subvariant will outpace the current dominant strain in circulation (XBB.1.5) and take the lead by summer.

member card

AARP Membership — $12 for your first year when you sign up for Automatic Renewal

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP The Magazine.

Join Now

What this means is that we could see another surge of infections over the coming months, Binnicker says. However, he suspects this new wave will not be as bad as previous ones, like when omicron and delta first burst onto the scene. 

A big reason: “There is a high level of existing immunity in the population, either [from] prior infection or from vaccination,” Binnicker says. This immunity reduces the risk of reinfection, or severe illness if a person is infected, though the CDC notes that protection does wane some over time.

More recently, health officials gave the all-clear for adults 65 and older and immunocompromised individuals to get a second bivalent booster to restore diminished protection. These updated vaccines, which first became available in September 2022, target both the original strain of the coronavirus and two omicron strains no longer in circulation. Data show the bivalent vaccines have been effective against other omicron subvariants that have emerged, and Binnicker predicts that will hold true with XBB.1.16.

Does the new subvariant cause new symptoms?

So far, there’s no sign that this subvariant causes people to get sicker, officials with the World Health Organization (WHO) say. In the U.S., hospitalizations and deaths from COVID-19 have been steadily declining since winter, federal data shows, though they remain highest among the older adult population.

However, symptoms may differ with XBB.1.16. Conjunctivitis, or pink eye, has been linked with COVID in the past, but Binnicker says some doctors in India have noted it’s popping up more often in people infected with XBB.1.16, especially in children. Some people may also experience higher fevers, he adds.

Health & Wellness

AARP Members Only Access to Special Health Content

Access AARP health Smart Guides, articles and special content

See more Health & Wellness offers >

“So those are two things for physicians to keep an eye on as we start to see an increase in prevalence here in the U.S.,” Binnicker says.

This time of year, the red, itchy eyes that accompany conjunctivitis could easily be blamed on seasonal allergies. Conjunctivitis can also be a symptom of other viral infections, such as adenovirus, which is spiking in the U.S. right now, national surveillance data shows. Binnicker says this underscores the importance of getting tested for COVID-19 if you experience any symptoms related to a coronavirus infection. With a positive test, you could be eligible for antiviral treatments that can significantly reduce your risk of severe COVID-19 complications.

Another tip: Stay vigilant. WHO Director Tedros Adhanom Ghebreyesus said in a recent media briefing that the emergence of XBB.1.16 illustrates that the “virus is still changing and is still capable of causing new waves of disease and death.” 

Video: What You Should Know About the New COVID Variant ‘Arcturus’

Join AARP to continue reading

Find exclusive interviews, smart advice, free novels, full documentaries, fun daily features and much more — all a benefit of your AARP membership — on Members Only Access.

Join AARP for Members Only Access

Already a Member?